ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance

OBJECTIVE Low plasma high-density lipoprotein cholesterol (HDL-C) concentration is associated with the metabolic syndrome (MetS) and increased prevalence of cardiovascular disease (CVD). Animal and human studies report infusion of apolipoprotein A-1 (apoA-1) can reduce endothelial dysfunction, and/o...

Full description

Bibliographic Details
Main Authors: Borthwick, F., Warnakula, S., Mangat, R., Uwiera, R., Russell, J., Kelly, S., Lee, C., Hryshko, L., Mamo, John, Rye, K., Lopaschuk, G., Proctor, S.
Format: Journal Article
Published: Elsevier Ireland 2012
Online Access:http://hdl.handle.net/20.500.11937/28338